--- schema_version: "secwatch.filing_event.v1" accession: "0001613103-23-000132" form_type: "8-K" ticker: "MDT" cik: "0001613103" company_name: "Medtronic plc" filed_at: "2023-10-23T23:59:59+00:00" generated_at: "2026-06-09T16:44:16.687762+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.5 calibrated_materiality_score: 0.5 confidence: "high" source: SEC EDGAR --- # Medtronic shareholders approve 2024 ESPP (30M shares); directors re-elected with notable dissent ## Summary - 2024 Employee Stock Purchase Plan approved; 30M ordinary shares authorized; first purchase period Jan 1, 2024. - All 11 director nominees re-elected; O'Leary (107M against) and Powell (102M against) faced largest opposition. - PwC ratified as FY2024 auditor: 1.06B for, 101.7M against; executive compensation advisory approved: 968M for, 68.9M against. - Shareholders approved renewal of authority to issue shares, opt out of pre-emption rights, and authorize overseas share repurchases. - 2014 ESPP to terminate after Dec 31, 2023 purchase period; no new periods under that plan after 2023. ## SEC filing metadata - accession: 0001613103-23-000132 - form_type: 8-K - ticker: MDT - cik: 0001613103 - company_name: Medtronic plc - filed_at: 2023-10-23T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.5 - calibrated_materiality_score: 0.5 - confidence: high - sec_items: 5.02, 5.07, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/mdt-20231019.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001613103-23-000132 - JSON: https://secwatch.observer/filing/0001613103-23-000132.json - Plain text: https://secwatch.observer/filing/0001613103-23-000132.txt ## Key facts - Shareholder Votes Medtronic plc shareholders approved Authorize overseas market purchases of ordinary shares at the 2023-10-19 meeting. - Outcome: passed - Meeting: 2023-10-19 source text: 7. The shareholders approved authorization of the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. FOR AGAINST ABSTAIN 1,107,883,517 52,096,146 4,187,303 evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm - Shareholder Votes Medtronic plc shareholders approved Election of eleven directors to hold office until the 2024 Annual General Meeting at the 2023-10-19 meeting. - Proposal: director election - Outcome: passed - Meeting: 2023-10-19 source text: 1. The shareholders elected each of the eleven nominees to the Board of Directors, to hold office until the 2024 Annual General Meeting of the Company and until his or her successor is elected, as follows: FOR AGAINST ABSTAIN BROKER NON-VOTE Craig Arnold 1,015,233,892 25,512,208 864,144 122,556,722 evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm - Shareholder Votes Medtronic plc shareholders approved Approve 2024 Employee Stock Purchase Plan at the 2023-10-19 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2023-10-19 source text: 4. The shareholders approved the Company's 2024 Employee Stock Purchase Plan. FOR AGAINST ABSTAIN BROKER NON-VOTE 1,033,704,001 3,320,010 4,586,233 122,556,722 evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm - Shareholder Votes Medtronic plc shareholders approved Renew Board's authority to issue shares at the 2023-10-19 meeting. - Outcome: passed - Meeting: 2023-10-19 source text: 5. The shareholders approved renewal of the Board’s authority to issue shares. FOR AGAINST ABSTAIN 1,145,356,737 16,259,098 2,551,131 evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm - Shareholder Votes Medtronic plc shareholders approved Renew Board's authority to opt out of pre-emption rights at the 2023-10-19 meeting. - Outcome: passed - Meeting: 2023-10-19 source text: 6. The shareholders approved renewal of the Board’s authority to opt out of pre-emption rights. FOR AGAINST ABSTAIN 1,090,829,831 70,342,442 2,994,693 evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm - Shareholder Votes Medtronic plc shareholders approved Ratify appointment of PricewaterhouseCoopers LLP as independent auditor and authorize Board to set remuneration at the 2023-10-19 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2023-10-19 source text: 2. The shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal year 2024 and authorized, in a binding vote, the Company’s Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration. FOR AGAINST ABSTAIN 1,060,656,333 101,691,327 1,819,306 evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm - Shareholder Votes Medtronic plc shareholders approved Non-binding advisory vote on named executive officer compensation at the 2023-10-19 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2023-10-19 source text: 3. The shareholders approved, on a non-binding advisory basis, the compensation awarded to the Company’s named executive officers. FOR AGAINST ABSTAIN BROKER NON-VOTE 968,139,099 68,905,223 4,565,922 122,556,722 evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000132/0001613103-23-000132-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.